Monkeypox Clinical Trials
41 clinical trials for Monkeypox across international registries, including 11 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Characterization of Vaccine-induced Responses Against Monkeypox (MoVIHvax) An Observational Prospective Cohort Study — RECRUITING
- Prospective Study for the FOLLOW-UP of Human Monkeypox Cases and Smallpox Vaccinees at Risk — RECRUITING
- Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses. — RECRUITING · PHASE1
- New York City Observational Study of Mpox Immunity — RECRUITING
- A Study Evaluating the Safety and Immunogenicity of MVA Strain Monkeypox Attenuated Live Vaccine — RECRUITING · PHASE1
- Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of Congo (Part2) — RECRUITING
- Evaluation of Long-term Immunogenicity of a Boost Dose of MVA-BN Vaccine — RECRUITING
- Epidemiological and Pathophysiological Insights Through a Cross-sectional Survey (EPIC) — RECRUITING
- European Trial Into Mpox Infection — RECRUITING · PHASE4
- Observational, Prospective, Cohort Study of Mpox Infection in Brazil (NETPOX) — RECRUITING
- PLACEBO-CONTROLLED RANDOMIZED TRIAL OF TECOVIRIMAT IN NONHOSPITALIZED PATIENTS WITH MPOX: CANADIAN FEASIBILITY STUDY — RECRUITING
- Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT — ACTIVE_NOT_RECRUITING · PHASE4
- Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure — OTHER
- Assessment of the Efficacy and Safety of Tecovirimat in Patients With Monkeypox Virus Disease — ACTIVE_NOT_RECRUITING · PHASE3
- Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV — TERMINATED
- Trial to Evaluate the Immunogenicity of Dose Reduction Strategies of the MVA-BN Monkeypox Vaccine — COMPLETED · PHASE2
- Understanding MPXV Viral Clearance, Transmission Dynamics, and Mpox Vaccine Effectiveness in West Africa : Guinea — NOT_YET_RECRUITING
- Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells — ACTIVE_NOT_RECRUITING · PHASE2
- A Clinical Study Investigating the Safety and Immune Responses After Immunization With Investigational Monkeypox Vaccines — COMPLETED · PHASE1
- A Phase 2 Randomized Multisite Trial to Inform Public Health Strategies Involving the Use of MVA-BN Vaccine for Mpox — COMPLETED · PHASE2
- Ocular Complications of Mpox in the Democratic Republic Congo — COMPLETED
- Tecovirimat in Non-hospitalized Patients With Monkeypox — SUSPENDED · PHASE3
- Assessment of Safety Profile of MVA-BN Vaccine in the PALM-007 Study in DRC — COMPLETED · PHASE4
- Prospective Follow-up After MVA-BN Booster Vaccination — NOT_YET_RECRUITING
- Evaluate the Safety and Immunogenicity of the MVA-SIBP Vaccine in the Democratic Republic of the Congo — NOT_YET_RECRUITING · PHASE2
- Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Orthopoxvirus Infections — ACTIVE_NOT_RECRUITING · PHASE2
- Tecovirimat for Treatment of Monkeypox Virus — COMPLETED · PHASE2
- Efficacy/Effectiveness, Safety, and Immunogenicity of LC16m8 Mpox Vaccine in Colombia — ACTIVE_NOT_RECRUITING · PHASE3
- Morbidity, Mortality And Risk Factors of Mpox in HIV Negative High Risk Sexual Health Clinic Attenders and People Living With HIV — COMPLETED
- Safety and Effectiveness of MVA-BN vaccination against MPXV infection in at-risk individuals in Germany — OTHER
- NAPKON - National Pandemic Cohort Network – Monkeypox Platform
Analysis of pathophysiology and pathology of Monkeypox Virus (MPV), including chronic morbidity — OTHER
- Clinical, Virological, Immunological, Psychosocial and Epidemiological Consequences of Human Monkeypox Virus (ProMPX) — TERMINATED
- Mpox Prospective Observational Cohort Study — OTHER
- Viral Clearance and Epidemiological Characteristics in Patients With Monkeypox — COMPLETED
- Study of the Safety, Tolerability, Pharmacokinetics of NIOCH-14 in Volunteers Aged 18-50 Years — COMPLETED · PHASE1
- Mpox Paediatric and Adolescent Clinical Study — OTHER
- Study on Immunogenicity, Reactogenicity and Safety of the VACΔ6 Vaccine in Volunteers Aged 18-60 Years — COMPLETED · PHASE2
- Safety and Tolerability Study of the VAC∆6 Vaccine in Volunteers Aged 18-40 Years — COMPLETED · PHASE1
- SMART (SMALLPOX VACCINE FOR MONKEYPOX POST-EXPOSURE PROPHYLAXIS: A CLUSTER RANDOMIZED CONTROLLED TRIAL) — NOT_YET_RECRUITING
- Pilot Study to Detect Monkey Pox Virus in Sperm: POXSPERM — OTHER · NA
- Cohort Study of Healthcare Workers Receiving Imvanex® — COMPLETED
Refine this search